Pharma Stocks Plunge on Trump Tariff Threat
New Delhi: Shares of Pharmaceutical companies on Friday tumbled up to 10 per cent amid reports that the Trump Administration will soon announce tariffs on pharma imports and emphasised that…
Aurobindo Pharma arm’s New Jersey warehouse gets OAI status after U.S. FDA inspection
The U.S. Food and Drug Administration (U.S. FDA) has classified a warehouse of Aurobindo Pharma subsidiary in New Jersey, U.S. as Official Action Indicated (OAI) after an inspection it conducted.…
Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drug
Aurobindo Pharma shares jumped 2% to an intraday high of Rs 1,265 on the BSE after its wholly owned step-down subsidiary CuraTeQ Biologics received approval from the UK‘s Medicines and Healthcare products Regulatory Agency…
Aurobindo Pharma signs pact with Covaxx for Covid-19 vaccine
Hyderabad: Aurobindo Pharma Ltd and Covaxx, a US-based company, have entered into an exclusive license agreement to develop, commercialise and manufacture UB-612, the first Multitope Peptide-based vaccine to fight Covid-19, for India and UNICEF. According…
Pharma sector business in US is going to be the most profitable
– Analysts expect sales to grow by around 15 percent in the first quarter of the fiscal year 2019-2020 led by sales in the US market. – US sales are likely…
Journalist Katherine Eben’s book ‘Bottle of Lies’ puts Indian drug companies in the dock
‘Bottle of Lies’ opens a can of worms for Indian drug companies. The new book by Katherine Eban, called an “invaluable exposé” by The New York Times, alleges severe cases…
Threat to Indian pharmaceutical company, may cost more than 6 thousand crores in the US
A total of 44 US states on Monday filed a lawsuit against as many as 20 generic drug manufacturers, including seven Indian firms. Among these Indian firms, 5 have been…
Aurobindo acquires 7 oncology drugs from spectrum for $300 million
Hyderabad: Aurobindo Pharma on Thursday said it has acquired seven marketed oncology injectable products from Spectrum Pharmaceuticals Inc for about $300 million, which includes an upfront cash payment of up…
